Total Funding
71
51
Total FundingPost-IPO Debt raised
Growth Score 71 in past quarter
-15 pts
Heat Score 51 in past quarter
-23 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
130287
Telo Genomics, a biotech company that offers telomere platform for biopsies and related technologies in oncology and neurological diseases.
- John Price: Chief Financial OfficerPast Role: National Beverage Properties, Chief Accounting Officer
- Sabine Mai: Co-founder, Director and Chair
About the Company
Telo Genomics, a biotech company that offers telomere platform for biopsies and related technologies in oncology and neurological diseases.